Subject: RXMD Seeks to Help Millions Affected by Opioid Epidemic

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
RXMD Seeks to Help Millions Affected by Opioid Epidemic
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Price: 0.066

Change (%): - 0.0015 (2.22)

Volume: 385,648
RXMD Chart

Progressive Care Launches Opioid Alternative Treatment Campaign Aimed at Reaching Millions Affected by the Nationwide Epidemic

MIAMI, June 12, 2018 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today launched a new program designed to educate patients and providers on treatment alternatives to opioids available through the company. The campaign is part of the company’s initiative to spread awareness of available alternative therapies that can improve a person’s quality of life and, in many cases, prevent tragedy caused by opioid abuse and solve the nationwide epidemic.

Beginning this month and running in digital and social properties, the campaign is targeted to physicians and patients who have been affected by the opioid epidemic and/or interested in receiving pain management information. The campaign is estimated to reach 20,000 patients and physicians.

“As one of the few providers in the nation that offers customized opioid alternative solutions for patients, as well as educates physicians on the current best pain management medicinal therapies and custom compound therapies, Progressive Care has a large opportunity to help alleviate the U.S. opioid epidemic,” said S. Parikh Mars, CEO of Progressive Care. “It is a serious issue and continues to cause incredible damage to patients and communities through tragic overdose, detrimental addictive behavior, and increased infectious disease rates. We hope that this program illustrates Progressive Care’s commitment to educating the public on the facts of opioid alternatives and combat this growing problem through available alternative treatments.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks